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INTRODUCTION 45 46
Streptococcus agalactiae (Lancefield Group B streptococcus [GBS]) is the most common cause of 47 serious bacterial illness in neonates. Incidence of GBS disease in neonates less than 90 days old is 48 0.43 per 1000 births, with a case fatality of 12% (1). Conventional detection of GBS from patient 49 samples using culture is both time-consuming and unreliable, particularly if samples are taken after 50 antibiotics are administered (2). Laboratory diagnosis involves culture of recto-vaginal swab samples 51 (when screening for antepartum or intrapartum carriage) and culture of blood and/or cerebrospinal 52 fluid (CSF) samples from unwell neonates or neonates known to have been exposed to maternal GBS 53
(3). Effective molecular tests for GBS would be valuable to clinicians by obviating the need for 54 several days of culture. Several quantitative real-time polymerase chain reaction (PCR) assays for 55 GBS have been developed and validated, most for use on vaginal swab samples rather than whole 56 blood (4-7). One recent study showed a real-time PCR assay to detect the cylB gene in blood and/or 57 CSF was significantly more sensitive than culture for diagnosis of GBS infection in neonates (2). 58 59 Effective DNA extraction from clinical specimens is critical for molecular pathogen detection. This is 60 particularly the case for whole blood, where the complex matrix and presence of PCR inhibitors can 61 make DNA extraction difficult (8, 9) . It is well established that different methods of sample 62 preparation and DNA extraction have a significant impact on overall assay sensitivity (10, 11). GBS is 63 a Gram-positive organism with a robust cell wall, and accordingly it can be difficult to lyse bacterial 64 cells to release genomic DNA (9). This makes molecular detection of GBS much more challenging 65 than, for example, Neisseria meningitidis (an easily-lysed Gram-negative organism) where PCR 66 testing is widely recognised as a gold standard method (12, 13) . 67 68 Molecular testing of neonatal blood and/or CSF specimens may improve the diagnosis of early-onset 69 sepsis caused by GBS, as detection of GBS DNA in a sterile site specimen would confirm the 70 diagnosis. However, failure to lyse GBS cells will adversely affect detection limits and clinical 71 sensitivity of molecular GBS tests. This study aimed to optimise extraction of GBS DNA from whole 72 blood, and to improve detection limits for molecular GBS detection. We report data from three 73 different pre-lysis methods and five different DNA extraction kits on the yield of GBS DNA from 74 spiked samples of saline and whole blood. Significant differences in yield were observed using 75 different extraction methods, with exceptionally low yields seen when commonly used extraction kits 76 were used without pre-lysis. 77 protocol was modified to include ACH pre-lysis between the two magnetic separations, prior to 125 removal of the magnetic beads. Buffer EN (400μl) was added to spiked EDTA whole blood (200μl) 126 and incubated with SpeedXtract Suspension A magnetic beads, according to the manufacturer's 127 protocol for liquid samples. Following magnetic separation, removal of supernatant and a wash step 128 using Buffer EN, the Suspension A beads were resuspended in ACH (100μl) and incubated at room 129 temperature for 5 minutes followed by heating to 95°C for 5 minutes. After ACH treatment, Buffer SL 130 (100μl) was added and samples were heated again to 95°C for 5 minutes before completing the 6 magnetic beads in Buffer SL (200μl) and heating to 95°C for 10 minutes. It was not feasible to 133 incorporate bead-beating into the SpeedXtract protocol without major deviation from the 134 manufacturer's protocol. Bead-beating would either lyse bacterial cells in blood prior to the first 135 magnetic separation (with loss of the bacterial DNA) or would require bead-beating of the magnetic 136 particles prior to the second magnetic separation (with possible mechanical breakdown of the 137 particles). 138
139
The QIAamp UCP Pathogen kit was not evaluated without pre-lysis or using ACH pre-lysis, as the 140 manufacturer's protocol specifies bead-beating. Conversely, bead-beating was not evaluated for the 141 QIAamp Blood Mini kit because the extraction chemistry is identical to the QIAamp UCP Pathogen 142 kit. Data from these two kits were therefore combined as a single "Qiagen column" method for 143 comparison with other methods. For both QIAamp kits, extraction columns were processed by 144 centrifugation, according to the manufacturer's instructions. For Fuji and Roche methods, the 145 QuickGene Mini-80 and MagNA Pure Compact systems were used respectively. Following extraction, 146 purified DNA was eluted using the manufacturers' elution buffer for each kit. Elution volume was 147 100μl for all methods, except SpeedXtract where 200μl elution was used. Combinations of different 148 sample pre-lysis and extraction methods introduced different overall dilution factors (Table S1) , so 149 appropriate corrections were required for calculation of yield. 150 7 (Sigma-Aldrich, Gillingham, U.K.). Ten-fold serial dilutions over a 6 log range were prepared for 160 qPCR calibration and to evaluate limits of detection. Corp., Texas, USA). 180 181 Data from the "high spike" samples are presented for numerical comparisons of yield, with 95% 182 confidence intervals (95% CI), whereas data from the "low spike" samples served to delineate the 183 lower limits of detection. Numerical comparison of yield for the "low spike" samples was not feasible 184 because the yield for many of the methods was so low that many (or all) replicates were negative for 185 GBS DNA when tested. Genome copy number data are shown for all PCR-positive samples.
Performance of qPCR assay 189 190
Efficiency of the sip gene qPCR, calculated from calibrator dilutions over a 6 log range (from 35 191 genome copies to 3.5 × 10 6 genome copies per reaction) was 100.3% with very high linearity (R 2 = 192 0.999), indicating the assay had excellent dynamic performance. The lower limit of detection for the 193 assay was found to be 7 genome copies per reaction, as 5/5 replicate assays were positive at that level 194 of dilution. Copy numbers below 7 per reaction were not evaluated. probably still underestimate the actual genome copy number in the spike, as the yield of the reference 206 extraction method is unlikely to be 100%. The yields of genomic DNA using other extraction methods 207 (each quantified using qPCR, as absolute genome copy numbers) were calculated relative to this 208 reference extraction method, and presented as "expected genome copies per ml". 209
210
As determined by reference extraction of aliquots of GBS cells suspension in PBS (using combined 211 bead-beating, ACH treatment and MagNA Pure extraction) there were 1.84 × 10 7 (95% CI 4.4 × 10 6 -involved in pre-lysis and extraction (Table S1) according to extraction protocol. Table 2 shows percentage yield of each extraction, relative to the 222 reference method, after taking into account the different dilution factors involved. 223
224
The overall effect of mechanical pre-lysis in the high spike samples was to increase yields of DNA by 225 51.3 fold (95% CI; 31.6 -85.1 fold, p<0.001) compared with no pre-treatment. Pre-lysis with ACH 226 increased yields by 6.1 fold (95% CI; 4.2 -8.9 fold, p<0.001). In preliminary experiments we found 227 that ACH treatment is ineffective in undiluted whole blood, and that a 1 in 4 dilution prior to ACH 228 treatment is optimal for maximal yield (data not shown). This introduces an unavoidable dilution step 229 in the ACH pre-lysis protocol for whole blood, compared with mechanical lysis (Table S1 ). Treatment 230 with ACH was slightly superior to mechanical lysis in terms of increased % recovery of DNA (1.8 fold 231 greater percentage recovery of DNA, p=0.020) but because the ACH pre-lysis protocol required more 232 sample dilution, the mechanical pre-lysis protocol gave higher overall higher yields of DNA. 233
234
There was no significant difference in DNA yield between the Qiagen and Fuji column-based 235 extraction methods (p=0.238). The MagNA Pure extraction method gave the highest absolute yield of 236 DNA, giving 1.96 fold greater yield than the column-based extraction methods (95% CI; 1.26 to 3.07 237 fold, p=0.004). The SpeedXtract system preformed slightly less well. The spin-column based methods 238 gave a yield 2.41 fold greater than the SpeedXtract kit (95% CI; 0.74 to 4.31 fold, p=0.004), although 239 the SpeedXtract protocol was the simplest, requiring only a magnetic rack. 240
Lower limits of detection 242 243
In the "low spike" experiments we investigated the lower limits of detection for GBS in whole blood 244 samples. Based on preliminary experiments the GBS load in these blood samples (1.68 × 10 4 genome 245 copies.mL -1 ) was expected to be at or below the limits of detection using some extraction methods 246 (data not shown). Due to the very low copy numbers expected, additional replicates were included in 247 these experiments. 248 249 Firstly, results were compared based on pre-lysis method. In low spike samples without any pre-lysis, 250 8/25 (32%) were positive for GBS DNA, with a mean genome copy number of 3.8 (95% CI; 3.0 -4.5) 251 copies per reaction in positive samples. In samples with mechanical pre-lysis, 18/18 (100%) were 252 positive for GBS DNA, with a mean copy number of 58.1 (95% CI; 42.2 -74.0) copies per reaction. 253
In samples with ACH pre-lysis, 16/34 (47%) were positive for GBS, with a mean copy number of 19.6 254 (95% CI; 5.3 -33.8) copies per reaction. Of note, in the low-spike samples using the ACH pre-lysis 255 protocol, 6/6 (100%) replicates extracted using the SpeedXtract system were positive for GBS DNA. 256
This compares to 5/10 (50%) using Qiagen Blood Amp Mini kit, 2/10 (20%) using the Fuji QuickGene 257 and 3/8 (37.5%) using MagNA Pure. As previously stated, ACH pre-lysis required a 1 in 4 dilution of 258 whole blood. The chemistry of the Speed Xtract kit is different from the other kits; the supernatant 259 containing most of the whole blood components is discarded early in the process following magnetic 260 separation. It was not possible to incorporate mechanical pre-lysis into this protocol, but ACH could be 261 used without an additional dilution step which may explain the superior performance. 262 263 Secondly, we compared the effects of extraction platform using samples without any pre-lysis (i.e. 264 exactly according to manufacturer's protocol). GBS DNA was detected in: 3/6 (50%) replicates 265 extracted using the Qiagen Blood Mini Kit with a mean of 3.6 (95% CI; 0.9 -6.3) genome copies per 266 reaction; 3/6 (50%) replicates extracted with the Speed Xtract kit with a mean of 3.7 (95% CI; 0.7 -267 6.7) genome copies per reaction; and 0/6 (0%) replicates extracted with the Fuji Quickgene extraction 268 platform. GBS DNA was detected in 2/7 (28.6%) replicates where samples were extracted using the 269
MagNA Pure system, with a mean of 4.1 (95% CI; 3.3 -4.9) genome copies per reaction. 270
271
Discussion 272
273
In this study, we found yields of S. agalactiae genomic DNA from blood, using several different 274 commercial DNA extraction kits, were extremely low. Unsurprisingly, much higher yields were seen 275 when kits were modified to include mechanical lysis, although the improvements using a very simple 276 and rapid enzyme treatment were also impressive. To our knowledge, no previous studies have 277 demonstrated use of ACH to improve lysis of S. agalactiae, or use of this enzyme at room 278 temperature. We also used higher ACH unit activities than reported for other Gram-positive bacteria. 279
Previous studies used arbitrary and varying amounts of ACH: 1000U/ml (18), 1500U/ml (15), 280 2000U/ml (16) or 4000U/ml (19). Using 4000U/ml, Niwa et al (19) reported complete lysis of a range 281 of Gram-positive bacteria in 10-15 minutes at 37ºC. Our method further increased the quantity of ACH 282 (to 9625U/ml) in a simple, fast (5 minute) room temperature protocol. There may be scope to further 283 improve yields by extending the incubation time, increasing the incubation temperature, or both. 284 285 Large differences in yield from the high-spike samples were seen between different extraction methods 286 using the same pre-lysis protocol. With no pre-lysis, or using bead-beating, both the Quickgene and 287
MagNA Pure methods consistently gave better performance than the Qiagen method. Using ACH pre-288 lysis, the yield for the Quickgene method was significantly reduced. The reasons for this are unclear. 289
Comparing all 3 pre-lysis protocols, the MagNA Pure method was the most effective overall. This 290 justified use of this method, with combined pre-lysis using both ACH and bead-beating, as the 291 reference method for estimation of genome copy number in the spiked samples, and for yield 292 calculations. The yields were lowest for extraction of the high-spike samples using the SpeedXtract 12 the smaller dilution factors involved) should be emphasised. This method is attractive in practical 295 terms, and ACH pre-lysis did increase yield, so additional work to optimise this approach for GBS 296 testing may be worthwhile. 297
298
In terms of cost, the requirement for an automated extraction system (i.e. a MagNA Pure Compact or 299
MagNA Pure 96 instrument) makes the MagNA Pure method significantly more expensive overall 300 than the other methods. The reagent cost for MagNA Pure extractions was also the highest 301 unreliable. It has previously been shown that molecular methods can be used to detect GBS in culture-311 negative EDTA-blood samples, although at a low rate; 2/35 culture-negative blood samples of babies 312 with probable sepsis were positive by PCR (2). As Qiagen Blood Mini kits were used to extract DNA 313 from samples without any pre-lysis in that study, our results suggest that poor DNA recovery may 314 have limited the sensitivity of PCR. 315
316
Recovering Gram-positive bacterial DNA from whole blood samples without a culture enrichment step 317 remains a challenge. The utility of direct PCR in addition to culture to detect septicaemia and 318 meningitis is well established for meningococcal septicaemia (12) , and PCR may become the gold 319 standard method for many other invasive bacterial infections, provided that optimised extraction 320 methods are used. 321 of GBS DNA with a mean increase of 6.1 fold and 51.3 fold respectively, after allowing for different 324 dilution factors for different protocols. The ACH pre-lysis method is straightforward, amenable to 325 high-throughput or routine use, and the enzyme retains lytic activity for GBS for 30 days when stored 326 at 4°C (data not shown). Although more effective overall, and requiring no dilution step, the 327 mechanical pre-lysis protocol requires a bead beating instrument and involves more hands-on sample 328 preparation time. 329 330 There is growing clinical interest in the use of rapid molecular tests to detect GBS in late pregnancy, 331 especially during labour, and in near-patient settings. Intrapartum screening of all pregnant women for 332 GBS using rapid molecular methods was recommended following a European consensus conference in 333 2015 (20). However, sub-optimal recovery of GBS DNA from clinical specimens is a potentially 334 important confounding factor that could affect the outcome of clinical trials in this area. A recent study 335 in France (21) concluded that intrapartum PCR testing could improve diagnosis and prevention of 336 GBS disease, compared to culture-based screening earlier in pregnancy. The study did not directly 337 compare the analytical performance of PCR to intrapartum culture, although a separate French study in 338 a different hospital (22) reported the sensitivity of intrapartum GBS PCR, compared to broth 339 enrichment culture, was 94.4%. A Japanese study (23) concluded that intrapartum PCR testing for 340 GBS was effective, although sensitivity was only 83.3% compared to broth enrichment culture on 341 specimens collected at the same time. 342 343 Our data suggest that problems with DNA extraction efficiency could adversely affect the performance 344 of molecular tests to detect GBS in clinical specimens, leading to underestimation of both analytical 345 and clinical sensitivity, and systematic bias in clinical trials. Unless this issue is properly evaluated and 346 addressed, these problems might limit the clinical utility of these potentially very important testing 347 methods for rapid detection of GBS in intrapartum screening and diagnosis of neonatal infections. 
